Anna Chaimani - Epidemiology

Author Information

Anna Chaimani is currently affiliated with the Department of Hygiene and Epidemiology at the University of Ioannina School of Medicine, located in Ioannina, Greece. Her work is primarily focused on epidemiological research, with a strong emphasis on meta-analysis and systematic reviews. Her contributions are crucial in the field of evidence-based medicine, helping to synthesize complex data and provide clear insights into various health interventions and treatments.

Research Contributions

Anna Chaimani has made significant contributions to the field of epidemiology, particularly through her work on network meta-analyses and systematic reviews. Her research covers a wide array of medical topics, including the efficacy of COVID-19 treatments and vaccines, pharmacological interventions for chronic conditions like psoriasis and hypertension, and the development of reporting guidelines for meta-analyses. Notably, her work on interleukin-blocking agents for COVID-19 treatment and the comparative efficacy of catheter ablation strategies for atrial fibrillation highlights her focus on improving clinical outcomes through comprehensive data analysis.

Aliases

Anna Chaimani is recognized in academic publications under the aliases "A. Chaimani" and "Anna Chaimani". These variations are commonly used in her scholarly works.

Publication and Citation Metrics

Metric	Value
Total Citation Count	14,281
H-index	42
Total Paper Count	136

Publications:

Comparing Efficacy and Safety in Catheter Ablation Strategies for Paroxysmal Atrial Fibrillation: A Network Meta-Analysis of Randomized Controlled Trials

DOI: 10.3390/diagnostics12020433

Year: 2022

Interleukin-1 blocking agents for treating COVID-19.

DOI: 10.1002/14651858.CD015308

Year: 2022

Do reporting guidelines have an impact? Empirical assessment of changes in reporting before and after the PRISMA extension statement for network meta-analysis

DOI: 10.1186/s13643-021-01780-9

Year: 2021

Interleukin-6 blocking agents for treating COVID-19: a living systematic review.

DOI: 10.1002/14651858.CD013881

Year: 2021

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

DOI: 10.1002/14651858.CD011535.pub4

Year: 2021

Do Reporting Guidelines Have an Impact? Empirical Assessment of Changes in Reporting Before and After the PRISMA Extension Statement for Network Meta-analysis

DOI: 10.21203/rs.3.rs-169601/v1

Year: 2021

Protocol effectiveness of COVID-19 vaccines on variant of concern. A systematic review of observational studies

DOI: 10.5281/ZENODO.5511936

Year: 2021

Introduction to Meta-Analysis

DOI: 10.1007/978-3-319-52677-5_287-1

Year: 2021

Comparative efficacy and acceptability of different antihypertensive drug classes for cardiovascular disease prevention: protocol for a systematic review and network meta-analysis

DOI: 10.1136/bmjopen-2020-044302

Year: 2021

Bayesian model-based outlier detection in network meta-analysis

DOI:

Year: 2021

What are the Public Health Measures to Control Biological Agents?

What is Rigor in Epidemiology?

Why is Interdisciplinary Training Important?

What Factors Influence the Spread of Vector-Borne Diseases?

How are Field Investigations Conducted?

How do global travel and trade influence disease spread?

How Does Genomics Aid in Understanding Disease Susceptibility?

What is the Role of Epidemiologists in This Context?

What is the Future of Big Data in Epidemiology?

What are the Key Components of Effective Health Communication?

Partnered Content Networks

Relevant Topics